JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Constantine Davides maintains a Market Outperform rating on HealthEquity (NASDAQ:HQY) and raises the price target from $101 to $105.
June 04, 2024 | 11:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has reaffirmed its Market Outperform rating on HealthEquity and increased the price target from $101 to $105, indicating confidence in the company's future performance.
The reaffirmation of the Market Outperform rating and the increase in the price target suggest that the analyst has a positive outlook on HealthEquity's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100